Related references
Note: Only part of the references are listed.The impact of prophylactic salpingo-oophorectomy on menopausal symptoms and sexual function in women who carry a BRCA mutation
A. Finch et al.
GYNECOLOGIC ONCOLOGY (2011)
Breast Cancer Risk in Relation to the Interval Between Menopause and Starting Hormone Therapy
Valerie Beral et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Menopausal Hormone Therapy and Risk of Endometrial Carcinoma Among Postmenopausal Women in the European Prospective Investigation into Cancer and Nutrition
Naomi E. Allen et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2010)
Menopausal Hormone Therapy and Subsequent Risk of Specific Invasive Breast Cancer Subtypes in the California Teachers Study
Tanmai Saxena et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
Estrogen Plus Progestin and Breast Cancer Incidence and Mortality in Postmenopausal Women
Rowan T. Chlebowski et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Breast Cancer Risk by Breast Density, Menopause, and Postmenopausal Hormone Therapy Use
Karla Kerlikowske et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial
Jack Cuzick et al.
LANCET ONCOLOGY (2010)
Control of mammary stem cell function by steroid hormone signalling
Marie-Liesse Asselin-Labat et al.
NATURE (2010)
Progesterone induces adult mammary stem cell expansion
Purna A. Joshi et al.
NATURE (2010)
Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer
Daniel Schramek et al.
NATURE (2010)
Postmenopausal Hormone Use and Breast Cancer Associations Differ by Hormone Regimen and Histologic Subtype
Eugenia E. Calle et al.
CANCER (2009)
Breast Cancer after Use of Estrogen plus Progestin in Postmenopausal Women
Rowan T. Chlebowski et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
Steven R. Cummings et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Biomarkers of Induced Active and Passive Smoking Damage
Maura Lodovici et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2009)
Conjugated equine estrogens and breast cancer risk in the women's health initiative clinical trial and observational study
Ross L. Prentice et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2008)
Estrogen plus progestin therapy and breast cancer in recently postmenopausal women
Ross L. Prentice et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2008)
Progestins in hormone replacement therapies reactivate cancer stem cells in women with preexisting breast cancers: A hypothesis
Kathryn B. Horwitz et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Hormone therapy and the risk of breast cancer in BRCA1 mutation carriers
Andrea Eisen et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Increased risk of recurrence after hormone replacement therapy in breast cancer survivors
Lars Holmberg et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Declining breast cancer incidence and decreased HRT use
Merethe Kumle
LANCET (2008)
The Nottingham prognostic index for invasive carcinoma of the breast
Andrew H. S. Lee et al.
PATHOLOGY & ONCOLOGY RESEARCH (2008)
Rare steroid receptor-negative basal-like tumorigenic cells in luminal subtype human breast cancer xenografts
Kathryn B. Horwitzt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
The decrease in breast-cancer incidence in 2003 in the United States.
Peter M. Ravdin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Prior hormone therapy and breast cancer risk in the Women's Health initiative randomized trial of estrogen plus progestin
Garnet L. Anderson et al.
MATURITAS (2006)
Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy
ML Stefanick et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Rate of over-diagnosis of breast cancer 15 years after end of Malmo mammographic screening trial: follow-up study
S Zackrisson et al.
BRITISH MEDICAL JOURNAL (2006)
Breast cancer risk with postmenopausal hormonal treatment
JA Collins et al.
HUMAN REPRODUCTION UPDATE (2005)
An overview of menopausal oestrogen-progestin hormone therapy and breast cancer risk
SA Lee et al.
BRITISH JOURNAL OF CANCER (2005)
Hormone use for menopausal symptoms and risk of breast cancer. A Danish cohort study
M Ewertz et al.
BRITISH JOURNAL OF CANCER (2005)
Effects of conjugated, equine estrogen in postmenopausal women with hysterectomy - The women's health initiative randomized controlled trial
GL Anderson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
National use of postmenopausal hormone therapy - Annual trends and response to recent evidence
AL Hersh et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Genotoxicity of steroidal estrogens
J Russo et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2004)
Mortality in relation to smoking: 50 years' observations on male British doctors
R Doll et al.
BMJ-BRITISH MEDICAL JOURNAL (2004)
Hormone therapy prescribing patterns in the United States
DSM Buist et al.
OBSTETRICS AND GYNECOLOGY (2004)
Short-term biologic response to withdrawal of hormone replacement therapy in patients with invasive breast carcinoma
R Prasad et al.
CANCER (2003)
Breast cancer and hormone-replacement therapy in the Million Women Study
E Banks et al.
LANCET (2003)
Influence of estrogen plus progestin on breast, cancer and mammography in healthy postmenopausal women - The Women's Health Initiative Randomized trial
RT Chlebowski et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Risks and benefits of estrogen plus progestin in healthy postmenopausal women - Principal results from the Women's Health Initiative randomized controlled trial
JE Rossouw et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Body mass index, height, and postmenopausal breast cancer mortality in a prospective cohort of US women
JM Petrelli et al.
CANCER CAUSES & CONTROL (2002)
Hormone replacement therapy (HRT) - risks and benefits
E Barrett-Connor et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2001)
Effect of hormone replacement therapy on breast cancer risk: Estrogen versus estrogen plus progestin
RK Ross et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Share Paper
